Dr. Mingyu Xue is currently a Principal at Aulis Capital. Prior to joining Aulis, Mingyu was a Vice President at MPC Investments (formerly known as Matrix Partners China), focusing on biotech venture investments and company incubation in China and the US. Previously, Mingyu was an Associate Director of Business Development and Licensing at Sanofi and before that, a Senior Consultant at Bain & Company.

Mingyu holds a PhD in Chemistry and Chemical Biology from Harvard University and a BSc in Chemistry from The University of Hong Kong. He completed postdoctoral training at Weill Cornell Medical College. He was a gold medalist in the International Chemistry Olympiad.